The study linked in this post is outdated and the information contained therein have been proven wrong in several follow-up peer-reviewed studies.
- FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems (https://www.fda.gov/drugs/drug-safety-and-availability/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or)
- Treatment with hydroxychloroquine is associated with increased mortality in COVID-19 patients, and there is no benefit of chloroquine (https://www.nature.com/articles/s41467-021-22446-z)
RE: September 15, 2021. Early Treatment with Hydroxychloroquine May Reduce COVID-19 Pneumonia Progression